A fibre-optic probe which measures the amount of oxygen in tumours may help
doctors to reduce the side effects of chemotherapy. Tumours with high oxygen
levels are more susceptible to treatment, so researchers at Mount Vernon
Hospital, Middlesex, hope the probe will allow them to identify tumours which
require less chemotherapy and radiotherapy. The probe, called Oxylite, was
invented by Oxford Optronix. Its clinical development is being funded by the
Cancer Research Fund.
More from 91av
Explore the latest news, articles and features
Popular articles
Trending 91av articles
1
100-year-old assumption about the universe may soon be overturned
2
Why the keto diet could be a revolutionary way to treat mental illness
3
The bombshell results that demand a new theory of the universe
4
Why your opinion of used electric vehicles is probably wrong
5
QBox theory may offer glimpse of reality deeper than quantum realm
6
How your heart rate variability can offer an insight into your mind
7
Largest-ever octopus was great white shark of invertebrate predators
8
10,000 new planets found hidden in NASA telescope data
9
Symptoms of early dementia reversed by bespoke treatment plans
10
Crisis in cosmology: If we’ve got dark energy wrong, what could it be?
